Voting Results of the Annual General Meeting held on 22nd September, 2025
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
OneSource Specialty Pharma Limited held its 18th AGM on September 22, 2025 via video conferencing, where all 6 resolutions were passed with voting conducted through remote e-voting and e-voting at the AGM. The resolutions covered adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, re-appointment of Arun Kumar (DIN: 00084845) as a retiring Director, approval of remuneration to Cost Auditor M. Ashok Kumar for FY 2025-26, and appointment of M/s. DV & Associates as Secretarial Auditors for a 5-year term. The two related party transaction (RPT) resolutions — with Strides Pharma Science Limited and Strides Pharma Inc, USA — passed with 92.04% votes in favour, though public institutions voted 79.25% in favour with about 20.75% voting against. Overall voting turnout was about 63% of outstanding shares, with 49 shareholders (4 promoters and 45 public) attending via VC. Pradeep B Kulkarni of V. Sreedharan and Associates served as Scrutinizer.
All routine AGM items including financial statements adoption and director re-appointment were passed with overwhelming support, indicating no shareholder concern on governance matters. The two material RPT approvals with Strides group entities, while passed, saw notable dissent (~21% against) from public institutional investors, which investors should monitor as a sign of governance scrutiny on related party deals.